COVID-19 vaccine safety and nocebo-prone associated hesitancy in patients with systemic rheumatic diseases: a cross-sectional study.
George E FragoulisVassiliki-Kalliopi BourniaEugenia MavreaGerasimos EvangelatosKalliopi FragiadakiAnastasios KaramanakosEyrydiki KravaritiKaterina LaskariStylianos T PanopoulosMaria PappaDimos-Dimitrios D MitsikostasMaria G G TektonidouDimitrios VassilopoulosPetros P SfikakisPublished in: Rheumatology international (2021)
No new safety signals for COVID-19 vaccination were observed. Vaccination campaign should target SRD patients with nocebo-prone and negative influenza vaccination behaviour.